We first focused on known oncogenes and tumor suppressors, and found that among the 30 most-frequently mutated cancer driver genes, only two (EGFR and TP53) were associated with prognosis in more than two tumor types (Figure 1C). This evidence concerns the gene EGFR and neoplasm.